173 related articles for article (PubMed ID: 21611756)
1. Roles of organic anion/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins.
Hosoya K; Tachikawa M
Clin Exp Nephrol; 2011 Aug; 15(4):478-85. PubMed ID: 21611756
[TBL] [Abstract][Full Text] [Related]
2. Live Tissue Imaging Reveals Distinct Transcellular Pathways for Organic Cations and Anions at the Blood-Cerebrospinal Fluid Barrier.
Hu T; Zha W; Sun A; Wang J
Mol Pharmacol; 2022 May; 101(5):334-342. PubMed ID: 35193935
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms of Organic Anion Transporting Polypeptide-Mediated Organic Anion Clearance at the Blood-Cerebrospinal Fluid Barrier.
Sun A; Hagenbuch B; Kelly EJ; Wang J
Mol Pharmacol; 2023 Dec; 104(6):255-265. PubMed ID: 37652713
[TBL] [Abstract][Full Text] [Related]
4. Fluid and ion transfer across the blood-brain and blood-cerebrospinal fluid barriers; a comparative account of mechanisms and roles.
Hladky SB; Barrand MA
Fluids Barriers CNS; 2016 Oct; 13(1):19. PubMed ID: 27799072
[TBL] [Abstract][Full Text] [Related]
5. SLC22A11 Inserts the Uremic Toxins Indoxyl Sulfate and P-Cresol Sulfate into the Plasma Membrane.
Tust M; Müller JP; Fischer D; Gründemann D
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894870
[TBL] [Abstract][Full Text] [Related]
6. Role of Organic Anion Transporter NPT4 in Renal Handling of Uremic Toxin 3-indoxyl Sulfate.
Imamura R; Sugimoto M; Horike SI; Terakawa J; Fujita K; Tamai I; Daikoku T; Kato Y; Arakawa H
J Pharm Sci; 2024 Jul; 113(7):1996-2000. PubMed ID: 38641061
[TBL] [Abstract][Full Text] [Related]
7. [Cognitive impairment and the blood-brain barrier in chronic kidney disease: role of the uremic toxins].
Bobot M
Nephrol Ther; 2023 Dec; 19(7):607-615. PubMed ID: 38059844
[TBL] [Abstract][Full Text] [Related]
8. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.
Tsuji A
NeuroRx; 2005 Jan; 2(1):54-62. PubMed ID: 15717057
[TBL] [Abstract][Full Text] [Related]
9. The organic anion transporter (OAT) family: a systems biology perspective.
Nigam SK; Bush KT; Martovetsky G; Ahn SY; Liu HC; Richard E; Bhatnagar V; Wu W
Physiol Rev; 2015 Jan; 95(1):83-123. PubMed ID: 25540139
[TBL] [Abstract][Full Text] [Related]
10. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
[TBL] [Abstract][Full Text] [Related]
11. Indoxyl Sulfate Induces Apoptosis Through Oxidative Stress and Mitogen-Activated Protein Kinase Signaling Pathway Inhibition in Human Astrocytes.
Lin YT; Wu PH; Tsai YC; Hsu YL; Wang HY; Kuo MC; Kuo PL; Hwang SJ
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30764571
[TBL] [Abstract][Full Text] [Related]
12. circRNA-PTPN4 mediated regulation of FOXO3 and ZO-1 expression: implications for blood-brain barrier integrity and cognitive function in uremic encephalopathy.
Liu Y; Qin Y; Zhang Y
Cell Biol Toxicol; 2024 Apr; 40(1):22. PubMed ID: 38630149
[TBL] [Abstract][Full Text] [Related]
13. Indoxyl sulphate-TNFα axis mediates uremic encephalopathy in rodent acute kidney injury.
Jiang L; Sun XY; Wang SQ; Liu YL; Lu LJ; Wu WH; Zhi H; Wang ZY; Liu XD; Liu L
Acta Pharmacol Sin; 2024 Jul; 45(7):1406-1424. PubMed ID: 38589687
[TBL] [Abstract][Full Text] [Related]
14. Ionic liquid-coated lipid nanoparticles increase siRNA uptake into CNS targets.
Khare P; Edgecomb SX; Hamadani CM; Conway JF; Tanner EEL; S Manickam D
Nanoscale Adv; 2024 Mar; 6(7):1853-1873. PubMed ID: 38545295
[TBL] [Abstract][Full Text] [Related]
15. 4-Ethylphenol-fluxes, metabolism and excretion of a gut microbiome derived neuromodulator implicated in autism.
Day F; O'Sullivan J; Pook C
Front Mol Biosci; 2023; 10():1267754. PubMed ID: 37900921
[TBL] [Abstract][Full Text] [Related]
16. How Much is Enough? Impact of Efflux Transporters on Drug delivery Leading to Efficacy in the Treatment of Brain Tumors.
Zhang W; Oh JH; Zhang W; Rathi S; Le J; Talele S; Sarkaria JN; Elmquist WF
Pharm Res; 2023 Nov; 40(11):2731-2746. PubMed ID: 37589827
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Synthetic Drugs and Natural Actives Interacting with OAT3.
Chen Y; Li H; Wang K; Wang Y
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375294
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
